J. Vičar

524 total citations
29 papers, 388 citations indexed

About

J. Vičar is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, J. Vičar has authored 29 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in J. Vičar's work include Chemical Synthesis and Analysis (7 papers), Peptidase Inhibition and Analysis (7 papers) and Protease and Inhibitor Mechanisms (6 papers). J. Vičar is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Peptidase Inhibition and Analysis (7 papers) and Protease and Inhibitor Mechanisms (6 papers). J. Vičar collaborates with scholars based in Czechia, France and Russia. J. Vičar's co-authors include K. Bláha, E Kr̆epela, Miloš Buděšı́nský, Jitka Ulrichová, Serge Fermandjian, P. Fromageot, Vilı́m Šimánek, I. Frič, Rostislav Večeřa and David Rasnick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Cell Science and FEBS Letters.

In The Last Decade

J. Vičar

28 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Vičar Czechia 13 203 73 69 64 61 29 388
Manfred Philipp United States 13 392 1.9× 109 1.5× 94 1.4× 18 0.3× 43 0.7× 28 626
Masaharu Hirata Japan 13 287 1.4× 109 1.5× 46 0.7× 46 0.7× 18 0.3× 35 514
Stanley J. Schmidt United States 12 323 1.6× 193 2.6× 62 0.9× 53 0.8× 33 0.5× 21 546
Kathleen A. Merkler United States 15 382 1.9× 46 0.6× 90 1.3× 106 1.7× 130 2.1× 20 630
Lars Nærum Denmark 14 272 1.3× 249 3.4× 58 0.8× 49 0.8× 40 0.7× 17 592
Allan Hallett United Kingdom 12 405 2.0× 227 3.1× 67 1.0× 31 0.5× 25 0.4× 17 621
J.M. Fernández-Sousa Spain 9 284 1.4× 56 0.8× 44 0.6× 59 0.9× 56 0.9× 12 454
Sumiko Tanaka Japan 11 148 0.7× 58 0.8× 138 2.0× 69 1.1× 47 0.8× 21 395
Geoffrey W. Mellor United Kingdom 14 348 1.7× 106 1.5× 103 1.5× 24 0.4× 86 1.4× 27 525
Hiroo Horinishi Japan 16 413 2.0× 153 2.1× 141 2.0× 26 0.4× 32 0.5× 29 688

Countries citing papers authored by J. Vičar

Since Specialization
Citations

This map shows the geographic impact of J. Vičar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Vičar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Vičar more than expected).

Fields of papers citing papers by J. Vičar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Vičar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Vičar. The network helps show where J. Vičar may publish in the future.

Co-authorship network of co-authors of J. Vičar

This figure shows the co-authorship network connecting the top 25 collaborators of J. Vičar. A scholar is included among the top collaborators of J. Vičar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Vičar. J. Vičar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vičar, J., Miroslav Soural, & Jan Hlaváč. (2010). Separation of Quaternary Benzo[c]phenanthridine Alkaloids from Macleaya cordata. Chemické listy. 104(1). 1 indexed citations
2.
Večeřa, Rostislav, Bořivoj Klejdus, Pavel Kosina, et al.. (2007). Disposition of sanguinarine in the rat. Xenobiotica. 37(5). 549–558. 32 indexed citations
3.
Psotová, Jitka, Rostislav Večeřa, Adéla Zdařilová, et al.. (2006). Safety assessment of sanguiritrin, alkaloid fraction of Macleaya cordata, in rats. Veterinární Medicína. 51(4). 145–155. 50 indexed citations
4.
Šimánek, Vilı́m, Radim Vespalec, Aleksi Šedo, Jitka Ulrichová, & J. Vičar. (2005). Quaternary Benzo[c]phenanthridine Alkaloids: Biological Activities. ChemInform. 36(16). 1 indexed citations
5.
Šimánek, Vilı́m, J. Vičar, Vladimı́r Křen, et al.. (2001). ["Silymarin"--an extract from the milk thistle (Silybum marianum)--is it a drug or nutritional supplement?].. PubMed. 50(2). 66–9. 3 indexed citations
6.
Kr̆epela, E, et al.. (1989). Cathepsin B in human breast tumor tissue and cancer cells.. PubMed. 36(1). 41–52. 26 indexed citations
7.
Kr̆epela, E, et al.. (1989). Cathepsin B in cells of two rat sarcomas with different rates of spontaneous metastasis.. PubMed. 36(5). 529–40. 5 indexed citations
8.
Rasnick, David, et al.. (1987). A latent form of cathepsin B in pleural effusions. Biochemical Medicine and Metabolic Biology. 38(2). 219–227. 7 indexed citations
9.
Kolář, Zdeněk, et al.. (1987). Clinical experience with the testing of serum proteinase activity by cathepsin B-like sensitive amino acid derivatives of 7-amino-4-methylcoumarine.. PubMed. 34(5). 601–8. 3 indexed citations
10.
Kr̆epela, E, Jiří Bártek, J. Vičar, et al.. (1987). Cytochemical and biochemical evidence of cathepsin B in malignant, transformed and normal breast epithelial cells. Journal of Cell Science. 87(1). 145–154. 32 indexed citations
11.
Kr̆epela, E, E Kasafírek, J. Vičar, & J Kraml. (1983). An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-L-proline-1-naphthylamide and other glycyl-L-proline-arylamides as substrates.. PubMed. 32(4). 334–45. 10 indexed citations
12.
Vičar, J., F. Toma, François Piriou, et al.. (1979). The two conformations of TRH in solution. FEBS Letters. 97(2). 275–278. 22 indexed citations
13.
Vičar, J., K. Bláha, François Piriou, P. Fromageot, & Serge Fermandjian. (1979). 13C‐13C couplings in 13C‐labeled cyclo (tri‐L‐prolyl) and the pyrrolidine ring conformation. Biopolymers. 18(4). 1021–1022. 4 indexed citations
14.
Vičar, J., et al.. (1977). The influence of organic solvents on the conformation of thyreotropin releasing factor (TRF) studied by circular dichroism. Collection of Czechoslovak Chemical Communications. 42(1). 79–89. 7 indexed citations
15.
Vičar, J., et al.. (1977). ChemInform Abstract: SYNTHESIS AND PROPERTIES OF TUFTSIN, L‐THREONYL‐L‐LYSYL‐L‐PROLYL‐L‐ARGININE. Chemischer Informationsdienst. 8(9). 2 indexed citations
16.
Fermandjian, Serge, et al.. (1975). 13C-nuclear magnetic resonance study of [85% 13C-enriched proline]thyrotropin releasing factor: 13C-13C vicinal coupling constants and conformation of the proline residue.. Proceedings of the National Academy of Sciences. 72(12). 4948–4952. 27 indexed citations
17.
Vičar, J. & K. Bláha. (1973). Amino acids and peptides. CXVI. Conformational factors in the isomerisation of cyclodipeptides. Collection of Czechoslovak Chemical Communications. 38(11). 3307–3311. 7 indexed citations
18.
Vičar, J., Miloš Buděšı́nský, & K. Bláha. (1973). Amino acids and peptides. CXIV. Proton magnetic reasonance studies of cyclodipeptides containing pipecolic acid, proline and/or 2-azetidinecarboxylic acid. Collection of Czechoslovak Chemical Communications. 38(7). 1940–1956. 35 indexed citations
19.
Bláha, K., et al.. (1972). Spectroscopic studies of cyclodipeptides containing pipecolic acid, proline and/or 2-azetidinecarboxylic acid. Tetrahedron Letters. 13(15). 1437–1440. 11 indexed citations
20.
Vičar, J., et al.. (1972). Amino acids and peptides. CIX. Synthesis and infrared spectroscopy of 2,5-piperazinediones derived from proline and pipecolic acid. Collection of Czechoslovak Chemical Communications. 37(12). 4060–4071. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026